Literature DB >> 4365116

Susceptibility of 1,500 isolates of Pseudomonas aeruginosa to gentamicin, carbenicillin, colistin, and polymyxin B.

I B Duncan.   

Abstract

A series of 1,500 strains of Pseudomonas aeruginosa was collected from a variety of sources to provide a group of strains which would truly represent the species. All of them were pyocine typed, and a wide range of types was included among the isolates from each source. The gentamicin, carbenicillin, colistin, and polymyxin minimal inhibitory concentration of each strain was measured by the agar dilution method employing the Steers inocula replicator. Over 99% of strains were inhibited by 8 mug of gentamicin per ml, by 256 mug of carbenicillin per ml, and by 4 mug of colistin per ml. The small number of strains more resistant to each antibiotic comprised a variety of different pyocine types. Few strains were found to be susceptible to tetracycline, chloramphenicol, kanamycin, or streptomycin at the single concentration tested.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4365116      PMCID: PMC428911          DOI: 10.1128/AAC.5.1.9

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Transfer of anibioic resistanceetween Pseudomonas aeruginosa, Escherichia coli, and other gram-negative bacilli in rns.

Authors:  E Roe; R J Jones; E J Lowbury
Journal:  Lancet       Date:  1971-01-23       Impact factor: 79.321

2.  Sensitivity of Pseudomonas aeruginosa to antibiotics: emergence of strains highly resistant to carbenicillin.

Authors:  E J Lowbury; H A Lilly; A Kidson; G A Ayliffe; R J Jones
Journal:  Lancet       Date:  1969-08-30       Impact factor: 79.321

3.  In vitro activity of carbenicillin against gram-negative bacilli.

Authors:  G P Bodey; L M Terrell
Journal:  J Bacteriol       Date:  1968-05       Impact factor: 3.490

4.  Typing of Pseudomonas pyocyanea by pyocine production.

Authors:  R R Gillies; J R Govan
Journal:  J Pathol Bacteriol       Date:  1966-04

5.  Carbenicillin, a new semisynthetic penicillin active against Pseudomonas aeruginosa.

Authors:  G N Rolinson; R Sutherland
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1967

6.  Microbiologic studies related to bacterial resistance to gentamicin.

Authors:  M J Weinstein; C G Drube; E L Moss; J A Waitz
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

7.  Further studies in the pyocine typing of Pseudomonas pyocyanea.

Authors:  J R Govan; R R Gillies
Journal:  J Med Microbiol       Date:  1969-02       Impact factor: 2.472

8.  Dosage of gentamicin for pseudomonas infections.

Authors:  J H Darrell; P M Waterworth
Journal:  Br Med J       Date:  1967-05-27

9.  Susceptibility of Pseudomonas aeruginosa to gentamicin sulfate in vitro: lack of correlation between disc diffusion and broth dilution sensitivity data.

Authors:  W H Traub
Journal:  Appl Microbiol       Date:  1970-07

10.  Effect of medium composition on the apparent sensitivity of Pseudomonas aeruginosa to gentamicin.

Authors:  L P Garrod; P M Waterworth
Journal:  J Clin Pathol       Date:  1969-09       Impact factor: 3.411

View more
  14 in total

1.  Infectious complications of burns casualties during the Yom-Kippur War.

Authors:  Y Sidi; B Bogokowski; H Tsur; B Tavdioglu; E Rubinstein
Journal:  Infection       Date:  1977       Impact factor: 3.553

2.  Editorial: The disc sensitivity test.

Authors: 
Journal:  Br Med J       Date:  1974-07-13

3.  Multidrug-resistant Pseudomonas aeruginosa in Brooklyn, New York: molecular epidemiology and in vitro activity of polymyxin B.

Authors:  S Bratu; J Quale; S Cebular; R Heddurshetti; D Landman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-03       Impact factor: 3.267

4.  RPL11, an R factor of Pseudomonas aeruginosa determining carbenicillin and gentamicin resistance.

Authors:  T R Korfhagen; J C Loper
Journal:  Antimicrob Agents Chemother       Date:  1975-01       Impact factor: 5.191

5.  Susceptibility of Pseudomonas aeruginosa to tobramycin or gentamicin alone and combined with carbenicillin.

Authors:  E L Anderson; P K Gramling; P R Vestal; W E Farrar
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

6.  Emergence of gentamicin- and carbenicillin-resistant Pseudomonas aeruginosa in a hospital environment.

Authors:  W Gaman; C Cates; C F Snelling; B Lank; A R Ronald
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

7.  Epidemiology of Pseudomonas aeruginosa infections investigated by pyocin typing.

Authors:  I B Duncan; E V Booth
Journal:  Can Med Assoc J       Date:  1975-04-05       Impact factor: 8.262

8.  Comparative activity of tobramycin and gentamicin against Pseudomonas, Proteus and Providencia species.

Authors:  I B Ducan; J L Penner
Journal:  Can Med Assoc J       Date:  1975-07-12       Impact factor: 8.262

9.  Pseudomonas aeruginosa R factors determining gentamicin plus carbenicillin resistance from patients with urinary tract colonizations.

Authors:  T R Korfhagen; J C Loper; J A Ferrel
Journal:  Antimicrob Agents Chemother       Date:  1975-01       Impact factor: 5.191

10.  Chemically defined antimicrobial susceptibility test medium for Pseudomonas aeruginosa.

Authors:  J H Jorgensen; J C Lee; P M Jones
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.